Whitehawk Therapeutics, Inc. is an innovative oncology company based in Morristown, New Jersey, specializing in the development of targeted therapies that leverage proprietary technologies to deepen the understanding of tumor biology. By personalizing treatment approaches based on the distinct biological profiles of individual tumors, the company aims to significantly enhance patient outcomes in cancer care. With a strong commitment to precision medicine, Whitehawk is well-positioned to contribute transformative advancements to the landscape of cancer therapeutics, aligning with the increasing industry shift towards individualized treatment strategies.